Michael Dugery

SonoMedix, Inc. engages in the development and commercialization of technology designed for monitoring blood coagulation and hemostatic status. It offers Nano-Acoustic Blood Analyzer platform (NABA) technology that helps to interrogate and detect blood properties at the molecular level. The company was founded by Adam D. Dakin and Michael Dugery on June 6, 2005 and is headquartered in Doylestown, PA.

SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Bioconnect Systems, Inc. provides surgical implants and techniques that form controlled vascular connections. It offers Optiflow, a family of anastomotic connectors that provides repeatable method for connecting vessels. The company was founded by Michael Dugery and Adam D. Dakin on May 8, 2006 and is headquartered in Ambler, PA.